Lunit Presents Studies at SITC 2021, Highlighting the Effectiveness of AI in Predicting Response to Immunotherapy in a Clinical Trial Setting
Nov 12, 2021
- Lunit to present three abstracts about its AI biomarker platform Lunit SCOPE IO, also to be demonstrated during the event in booth #423 - One immunotherapy combination study adds significant evidence for the potential value of using Lunit SCOPE IO in clinical practice to predict patient response to immunotherapy across multiple cancer types SEOUL, South Korea, Nov. 11, 2021 /PRNewswire/ -- Lunit today announced that it will present three abstracts at the upcoming Society